A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for Non-obstructive Hypertrophic Cardiomyopathy
22 locations incl. La Jolla
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07023614·Phase 2·Recruiting